Continuing review of an approved and ongoing study posing more than minimal risk that was initially approved by a convened IRB:

Respuesta :

Answer:

"must occur within 12 months of the approval date."

Explanation:

When it is required that a study has continuing review, the Institutional Review Board performs a continuing review of the subjects of the research at any time of the research deemed appropriate according to the extent of risk. The grant approval periods of the Institutional Review Board (IRB) is usually not more than a year from the date of approval.